The structure of iPLA<sub>2</sub>β reveals dimeric active sites and suggests mechanisms of regulation and localization.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29472584.
- Also identified by DOI 10.1038/s41467-018-03193-0 and PMC identifier 5823874.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Calcium-independent phospholipase A<sub>2</sub>β (iPLA<sub>2</sub>β) regulates important physiological processes including inflammation, calcium homeostasis and apoptosis. It is genetically linked to neurodegenerative disorders including Parkinson's disease. Despite its known enzymatic activity, the mechanisms underlying iPLA<sub>2</sub>β-induced pathologic phenotypes remain poorly understood. Here, we present a crystal structure of iPLA<sub>2</sub>β that significantly revises existing mechanistic models. The catalytic domains form a tight dimer. They are surrounded by ankyrin repeat domains that adopt an outwardly flared orientation, poised to interact with membrane proteins. The closely integrated active sites are positioned for cooperative activation and internal transacylation. The structure and additional solution studies suggest that both catalytic domains can be bound and allosterically inhibited by a single calmodulin. These features suggest mechanisms of iPLA<sub>2</sub>β cellular localization and activity regulation, providing a basis for inhibitor development. Furthermore, the structure provides a framework to investigate the role of neurodegenerative mutations and the function of iPLA<sub>2</sub>β in the brain.
Medical subject headings
- Group VI Phospholipases A2